Collier, Jenna L. http://orcid.org/0000-0002-4071-4986
Weiss, Sarah A. http://orcid.org/0000-0002-4155-0346
Pauken, Kristen E. http://orcid.org/0000-0002-4309-7880
Sen, Debattama R.
Sharpe, Arlene H. http://orcid.org/0000-0002-9736-2109
Article History
Received: 23 February 2021
Accepted: 29 April 2021
First Online: 17 June 2021
Competing interests
: A.H.S. has patents/pending royalties on the PD-1 pathway from Roche and Novartis. A.H.S. is on advisory boards for Surface Oncology, Elstar, SQZ Biotechnologies, Elpiscience, Selecta, Bicara and Monopteros, GlaxoSmithKline and Janssen, and consults for Novartis. A.H.S. has received research funding from Novartis, Roche, UCB, Ipsen, Quark, Merck and AbbVie unrelated to this project.
Free to read: This content has been made available to all.